Exley A R, Bacon P A, Luqmani R A, Kitas G D, Gordon C, Savage C O, Adu D
University of Birmingham, UK.
Arthritis Rheum. 1997 Feb;40(2):371-80. doi: 10.1002/art.1780400222.
To develop and validate the Vasculitis Damage Index (VDI) for the standardized clinical assessment of damage in the systemic vasculitides.
Using a nominal group consensus approach, the Birmingham Vasculitis Group generated guiding principles for assessment of damage in all systemic vasculitides. Damage was defined as irreversible change resulting from scars. Consensus principles were developed into the VDI, including guidelines for use, a list of items of damage, and a glossary.
For 100 surviving patients with systemic vasculitis, the median VDI score at last observation was 3 (range 0-8). Within the Wegener's granulomatosis subgroup, the median VDI score for 12 non-survivors was higher than for 47 survivors (non-survivors median score 7, interquartile range 5-8 versus survivors median score 4, interquartile range 2-5; P = 0.003). VDI scores for 100 patients with systemic vasculitis increased from initial presentation to last observation by a median score of 3 (range 1-4; P < 0.001). The VDI assesses more items and is more sensitive to change than other indices of damage (P < 0.001). Using the VDI, trained observers can produce moderately consistent damage scores.
The VDI is a sensitive, reproducible, comprehensive, and credible clinical tool for quantifying damage. The data presented herein should enable further validation and testing of the VDI in specific vasculitic syndromes, and should facilitate the comparison of different therapies.
开发并验证血管炎损伤指数(VDI),用于系统性血管炎损伤的标准化临床评估。
伯明翰血管炎研究组采用名义组共识法,制定了所有系统性血管炎损伤评估的指导原则。损伤定义为瘢痕导致的不可逆变化。共识原则被纳入VDI,包括使用指南、损伤项目列表和术语表。
对于100例存活的系统性血管炎患者,最后一次观察时的VDI中位数为3(范围0 - 8)。在韦格纳肉芽肿亚组中,12例非存活者的VDI中位数高于47例存活者(非存活者中位数为7,四分位间距5 - 8;存活者中位数为4,四分位间距2 - 5;P = 0.003)。100例系统性血管炎患者的VDI评分从初次就诊到最后一次观察,中位数增加了3(范围1 - 4;P < 0.001)。与其他损伤指标相比,VDI评估的项目更多,对变化更敏感(P < 0.001)。使用VDI,经过培训的观察者可得出中度一致的损伤评分。
VDI是一种用于量化损伤的敏感、可重复、全面且可靠的临床工具。本文提供的数据应能使VDI在特定血管炎综合征中得到进一步验证和测试,并有助于比较不同疗法。